KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Deferred Taxes (2016 - 2026)

Pfizer has reported Deferred Taxes over the past 18 years, most recently at -$12.0 million for Q1 2026.

  • Quarterly Deferred Taxes rose 98.19% to -$12.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$1.5 billion through Mar 2026, up 58.75% year-over-year, with the annual reading at -$2.1 billion for FY2025, 1.47% down from the prior year.
  • Deferred Taxes was -$12.0 million for Q1 2026 at Pfizer, up from -$433.0 million in the prior quarter.
  • Over five years, Deferred Taxes peaked at -$12.0 million in Q1 2026 and troughed at -$3.4 billion in Q4 2022.
  • The 5-year median for Deferred Taxes is -$765.0 million (2025), against an average of -$1.0 billion.
  • Year-over-year, Deferred Taxes plummeted 1627.27% in 2022 and then skyrocketed 98.19% in 2026.
  • A 5-year view of Deferred Taxes shows it stood at -$3.4 billion in 2022, then soared by 45.34% to -$1.9 billion in 2023, then rose by 8.18% to -$1.7 billion in 2024, then skyrocketed by 74.62% to -$433.0 million in 2025, then skyrocketed by 97.23% to -$12.0 million in 2026.
  • Per Business Quant, the three most recent readings for PFE's Deferred Taxes are -$12.0 million (Q1 2026), -$433.0 million (Q4 2025), and -$765.0 million (Q3 2025).